Treatment of neurodegenerative disease with sodium chlorite
US11938149B2 · kind B2 · utility
4Cited by
8References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 10, 2023 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jan 10, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.